According to the latest data from the Hong Kong Stock Exchange, on September 21, Lazard Asset Management LLC reduced its holdings in Sinopharm (01099) by 738,800 shares at a price of HK$15.1035 per share, for a total amount of approximately HK$11.1585 million.
Following the reduction, its latest shareholding stands at approximately 188 million shares, representing a latest shareholding ratio of 13.99%.